Five-Year Survival Rates
(from the National Cancer Institute's Physician Data Query system, July 2002)
Prognostic factors include grade of tumor, depth of myometrial invasion, and histology. High estrogen receptor levels have a favorable impact on prognosis.
Corpus
| Stage | Survival Rate |
|---|---|
| Stage 0 | 100% |
| Stage I | 70-95% |
| Stage II | up to 55% |
| Stage III | up to 25% |
| Stage IV | up to 5% |
Placenta
Hydatidiform mole 100% (if treated properly).
Suggested Citation
SEER Training Modules: Five-Year Survival Rates. U.S. National Institutes of Health, National Cancer Institute. Cited 05 January 2026. Available from: https://training.seer.cancer.gov.